Deerfield's Pharmaceutical Portfolio

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.

Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.

Perceive Pharma operates as a pharmaceutical company.

Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.

BlinkRx is a prescription access platform that connects patients to branded medications, ensuring transparent pricing and home delivery.

Bridge Medicines is a drug discovery company

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

Blade Therapeutics is a discovery stage drug development company.

We transform the management of OUD to help people begin and sustain recovery.

Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms.

Recovery Centers of America is fundamentally transforming the treatment of addiction and the capabilities of those in recovery

New American Therapeutics is a specialty pharmaceutical company that acquires, markets and develops products in select therapeutic areas.